Phathom Pharmaceuticals, Inc. financial data

Symbol
PHAT on Nasdaq
Industry
Pharmaceutical Preparations
Location
100 Campus Drive,, Suite 102, Florham Park, New Jersey
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - Jun 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 957 % +14.4%
Quick Ratio 2.26 %
Debt-to-equity -675 % -45.1%
Return On Equity 446 % +13.4%
Return On Assets -77.5 % +28%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 58.5 M shares +39.3%
Common Stock, Shares, Outstanding 58.5 M shares +34.3%
Entity Public Float 526 M USD +166%
Common Stock, Value, Issued 5 K USD +25%
Weighted Average Number of Shares Outstanding, Basic 58.4 M shares +37.8%
Weighted Average Number of Shares Outstanding, Diluted 58.4 M shares +37.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 1.91 M USD
Cost of Revenue 426 K USD
Research and Development Expense 47.9 M USD -26.7%
General and Administrative Expense 91.6 M USD +2.05%
Operating Income (Loss) -207 M USD -25.9%
Nonoperating Income (Expense) -39.4 M USD -30.3%
Net Income (Loss) Attributable to Parent -247 M USD -26.6%
Earnings Per Share, Basic -4.46 USD/shares +8.42%
Earnings Per Share, Diluted -4.46 USD/shares +8.42%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 322 M USD +149%
Inventory, Net 1.46 M USD
Assets, Current 340 M USD +143%
Property, Plant and Equipment, Net 1.96 M USD +53.9%
Operating Lease, Right-of-Use Asset 1.26 M USD -39.5%
Other Assets, Noncurrent 1.69 M USD +466%
Assets 356 M USD +148%
Accounts Payable, Current 8.4 M USD +74.9%
Accrued Liabilities, Current 16.5 M USD +106%
Contract with Customer, Liability, Current 16.5 M USD
Liabilities, Current 43.5 M USD +201%
Contract with Customer, Liability, Noncurrent 303 M USD
Operating Lease, Liability, Noncurrent 292 K USD -69.1%
Other Liabilities, Noncurrent 9.7 M USD +29.3%
Liabilities 505 M USD +116%
Retained Earnings (Accumulated Deficit) -1.01 B USD -32.2%
Stockholders' Equity Attributable to Parent -149 M USD -64.6%
Liabilities and Equity 356 M USD +148%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -69 M USD -74%
Net Cash Provided by (Used in) Financing Activities 9.9 M USD -29.6%
Net Cash Provided by (Used in) Investing Activities -40 K USD +81.3%
Common Stock, Shares Authorized 400 M shares 0%
Common Stock, Shares, Issued 58.5 M shares +34.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -59.2 M USD -129%
Interest Paid, Excluding Capitalized Interest, Operating Activities 3.74 M USD +46.9%
Deferred Tax Assets, Valuation Allowance 176 M USD +39.4%
Deferred Tax Assets, Gross 176 M USD +39.2%
Operating Lease, Liability 1.02 M USD -38.3%
Depreciation 500 K USD -2.72%
Payments to Acquire Property, Plant, and Equipment 40 K USD -81.3%
Lessee, Operating Lease, Liability, to be Paid 1.08 M USD -40.7%
Property, Plant and Equipment, Gross 4.22 M USD +46%
Operating Lease, Liability, Current 730 K USD +2.53%
Lessee, Operating Lease, Liability, to be Paid, Year Two 513 K USD -31.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 513 K USD -31.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 56 K USD -65.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 513 K USD -3.03%
Deferred Tax Assets, Operating Loss Carryforwards 120 M USD +39.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 40 M shares 0%
Unrecognized Tax Benefits 3.01 M USD +29.4%
Operating Lease, Payments 200 K USD 0%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 214 K USD +46.6%
Deferred Tax Assets, Net of Valuation Allowance 343 K USD -28.7%
Share-based Payment Arrangement, Expense 43.6 M USD +71.6%
Interest Expense 49.9 M USD +47.9%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%